Solventum (SOLV) Gains from Investment Securities (2025 - 2026)
Solventum posted quarterly Gains from Investment Securities of -$7.0 million for Q1 2026, down 240.0% year-on-year from $5.0 million in Q1 2025, and down 216.67% on a QoQ basis from $6.0 million in Q4 2025.
Solventum (SOLV) has 2 years of Gains from Investment Securities data on file, last reported at -$7.0 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 240.0% year-over-year to -$7.0 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (up 20.0% YoY), and the FY2025 full-year result was $18.0 million, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$7.0 million, down from $6.0 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $7.0 million in Q3 2025 and bottomed at -$7.0 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.00 Mn |
| Mar 31, 2026 | -7.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Mar 31, 2025 | 5.00 Mn |